메뉴 건너뛰기




Volumn 3, Issue 3, 2008, Pages

Permeability testing of biomaterial membranes

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATERIALS; BIOMATERIALS; CAPILLARITY; CELL CULTURE; CROSSLINKING; DEGRADATION; ELECTROPHORESIS; FIBROBLASTS; FOOD ADDITIVES; IMPLANTS (SURGICAL); LIQUIDS; MEMBRANES; PROTEINS; SEMICONDUCTOR DOPING; SOLIDS; SULFATE MINERALS;

EID: 52649114449     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/3/3/034119     Document Type: Article
Times cited : (12)

References (39)
  • 1
    • 33846781660 scopus 로고    scopus 로고
    • Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers
    • Hillaireau H et al 2007 Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers Int. J. Pharm. 331 148-52
    • (2007) Int. J. Pharm. , vol.331 , Issue.2 , pp. 148-152
    • Hillaireau, H.1    Al, E.2
  • 2
    • 34748880897 scopus 로고    scopus 로고
    • PEGylated bioactive molecules in biodegradable polymer microparticles
    • Schmidt P G et al 2007 PEGylated bioactive molecules in biodegradable polymer microparticles Expert Opin. Biol. Ther. 7 1427-36
    • (2007) Expert Opin. Biol. Ther. , vol.7 , Issue.9 , pp. 1427-1436
    • Schmidt, P.G.1    Al, E.2
  • 3
    • 37549058856 scopus 로고    scopus 로고
    • Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
    • Lindvall O and Wahlberg L U 2008 Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease? Exp. Neurol. 209 82-8
    • (2008) Exp. Neurol. , vol.209 , Issue.1 , pp. 82-88
    • Lindvall, O.1    Wahlberg, L.U.2
  • 4
    • 36649033827 scopus 로고    scopus 로고
    • In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-l-lysine-alginate microcapsules
    • Murua A et al 2007 In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-l-lysine-alginate microcapsules Biomacromolecules 8 3302-7
    • (2007) Biomacromolecules , vol.8 , Issue.11 , pp. 3302-3307
    • Murua, A.1    Al, E.2
  • 5
    • 0036378210 scopus 로고    scopus 로고
    • Delivery of erythropoitin by encapsulated myoblasts in a genetic model of severe anemia
    • Rinsch C et al 2002 Delivery of erythropoitin by encapsulated myoblasts in a genetic model of severe anemia Kidney Int. 62 1395-401
    • (2002) Kidney Int. , vol.62 , Issue.4 , pp. 1395-1401
    • Rinsch, C.1    Al, E.2
  • 6
    • 0035030502 scopus 로고    scopus 로고
    • Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia
    • Rinsch C et al 2001 Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia Gene Therapy 8 523-33
    • (2001) Gene Therapy , vol.8 , Issue.7 , pp. 523-533
    • Rinsch, C.1    Al, E.2
  • 7
    • 0034662015 scopus 로고    scopus 로고
    • Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression
    • Peduto G et al 2000 Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression Transplantation 70 78-85
    • (2000) Transplantation , vol.70 , pp. 78-85
    • Peduto, G.1    Al, E.2
  • 8
    • 0035865457 scopus 로고    scopus 로고
    • Inducing host acceptance to encapsulated xenogeneic myoblasts
    • Rinsch C et al 2001 Inducing host acceptance to encapsulated xenogeneic myoblasts Transplantation 71 345-51
    • (2001) Transplantation , vol.71 , Issue.3 , pp. 345-351
    • Rinsch, C.1    Al, E.2
  • 9
    • 0028049694 scopus 로고
    • Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: A preclinical study for the treatment of cancer pain
    • Joseph J M et al 1994 Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain Cell Transplant. 3 355-64
    • (1994) Cell Transplant. , vol.3 , pp. 355-364
    • Joseph, J.M.1    Al, E.2
  • 10
    • 0027288001 scopus 로고
    • Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances
    • Sagen J et al 1993 Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances J. Neurosci. 13 2415-23
    • (1993) J. Neurosci. , vol.13 , pp. 2415-2423
    • Sagen, J.1    Al, E.2
  • 11
    • 0033771207 scopus 로고    scopus 로고
    • Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells
    • Zurn A D et al 2000 Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells Cell Transplant. 9 471-84
    • (2000) Cell Transplant. , vol.9 , pp. 471-484
    • Zurn, A.D.1    Al, E.2
  • 12
    • 10644233978 scopus 로고    scopus 로고
    • In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings
    • Norton L W et al 2005 In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings Biomaterials 26 3285-97
    • (2005) Biomaterials , vol.26 , Issue.16 , pp. 3285-3297
    • Norton, L.W.1    Al, E.2
  • 13
    • 4544340443 scopus 로고    scopus 로고
    • Cellulose acetate hollow fiber membranes blended with phospholipid polymer and their performance for hemopurification
    • Ye S H, Watanabe J and Ishihara K 2004 Cellulose acetate hollow fiber membranes blended with phospholipid polymer and their performance for hemopurification J. Biomater. Sci. Polym. Ed. 15 981-1001
    • (2004) J. Biomater. Sci. Polym. Ed. , vol.15 , Issue.8 , pp. 981-1001
    • Ye, S.H.1    Watanabe, J.2    Ishihara, K.3
  • 14
    • 14844283729 scopus 로고    scopus 로고
    • Biocompatibility and stability of disulfide-crosslinked hyaluronan films
    • Liu Y, Shu X Z and Prestwich G D 2005 Biocompatibility and stability of disulfide-crosslinked hyaluronan films Biomaterials 26 4737-46
    • (2005) Biomaterials , vol.26 , Issue.23 , pp. 4737-4746
    • Liu, Y.1    Shu, X.Z.2    Prestwich, G.D.3
  • 15
    • 33646886616 scopus 로고    scopus 로고
    • Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: Mechanical properties and corneal epithelial cell interactions
    • Duan X and Sheardown H 2006 Dendrimer crosslinked collagen as a corneal tissue engineering scaffold: mechanical properties and corneal epithelial cell interactions Biomaterials 27 4608-17
    • (2006) Biomaterials , vol.27 , Issue.26 , pp. 4608-4617
    • Duan, X.1    Sheardown, H.2
  • 16
    • 5044241166 scopus 로고    scopus 로고
    • Influence of weak and covalent bonds on formation and hydrolysis of gelatin networks
    • Giraudier S et al 2004 Influence of weak and covalent bonds on formation and hydrolysis of gelatin networks Biomacromolecules 5 1662-6
    • (2004) Biomacromolecules , vol.5 , Issue.5 , pp. 1662-1666
    • Giraudier, S.1    Al, E.2
  • 18
    • 33750078388 scopus 로고    scopus 로고
    • Synthetic nerve guide implants in humans: A comprehensive survey
    • Schlosshauer B et al 2006 Synthetic nerve guide implants in humans: a comprehensive survey Neurosurgery 59 740-7 discussion 747-8
    • (2006) Neurosurgery , vol.59 , Issue.4 , pp. 740-747
    • Schlosshauer, B.1    Al, E.2
  • 19
    • 30944457288 scopus 로고    scopus 로고
    • Physical and biological performance of a novel block copolymer nerve guide
    • Lietz M et al 2006 Physical and biological performance of a novel block copolymer nerve guide J. Biotech. Bioeng. 5 99-109
    • (2006) J. Biotech. Bioeng. , vol.93 , Issue.1 , pp. 99-109
    • Lietz, M.1    Al, E.2
  • 20
    • 0036010289 scopus 로고    scopus 로고
    • Development of a bioartificial nerve graft I. Design based on a reaction-diffusion model
    • Rutkowski G E and Heath C A 2002 Development of a bioartificial nerve graft I. Design based on a reaction-diffusion model Biotechnol. Prog. 18 362-72
    • (2002) Biotechnol. Prog. , vol.18 , Issue.2 , pp. 362-372
    • Rutkowski, G.E.1    Heath, C.A.2
  • 21
    • 33748336919 scopus 로고    scopus 로고
    • Scarring impedes regeneration at sites of peripheral nerve repair
    • Atkins S et al 2006 Scarring impedes regeneration at sites of peripheral nerve repair Neuroreport 17 1245-9
    • (2006) Neuroreport , vol.17 , Issue.12 , pp. 1245-1249
    • Atkins, S.1    Al, E.2
  • 22
    • 0347628883 scopus 로고    scopus 로고
    • Effects of hyaluronic acid on peripheral nerve scarring and regeneration in rats
    • Ozgenel G Y 2003 Effects of hyaluronic acid on peripheral nerve scarring and regeneration in rats Microsurgery 23 575-81
    • (2003) Microsurgery , vol.23 , Issue.6 , pp. 575-581
    • Ozgenel, G.Y.1
  • 23
    • 16244396148 scopus 로고    scopus 로고
    • Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier
    • Steuer H et al 2005 Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier Invest. Ophthalmol. Vis. Sci. 46 1047-53
    • (2005) Invest. Ophthalmol. Vis. Sci. , vol.46 , Issue.3 , pp. 1047-1053
    • Steuer, H.1    Al, E.2
  • 24
    • 1942455881 scopus 로고    scopus 로고
    • In vitro model of the outer blood-retina barrier
    • Steuer H et al 2004 In vitro model of the outer blood-retina barrier Brain Res. Brain Res. Protoc. 13 26-36
    • (2004) Brain Res. Brain Res. Protoc. , vol.13 , Issue.1 , pp. 26-36
    • Steuer, H.1    Al, E.2
  • 25
    • 0029060204 scopus 로고
    • Axonal guidance in the chicken retina
    • Stier H and Schlosshauer B 1995 Axonal guidance in the chicken retina Development 121 1443-54
    • (1995) Development , vol.121 , pp. 1443-1454
    • Stier, H.1    Schlosshauer, B.2
  • 26
    • 38349039417 scopus 로고    scopus 로고
    • Mineralised collagen-an artificial, extracellular bone matrix-improves osteogenic differentiation of bone marrow stromal cells
    • Bernhardt A, Lode A, Boxberger S, Pompe W and Gelinsky M 2007 Mineralised collagen-an artificial, extracellular bone matrix-improves osteogenic differentiation of bone marrow stromal cells J. Mater. Sci. Mater. Med. 19 269-75
    • (2007) J. Mater. Sci. Mater. Med. , vol.19 , Issue.1 , pp. 269-275
    • Bernhardt, A.1    Lode, A.2    Boxberger, S.3    Pompe, W.4    Gelinsky, M.5
  • 27
    • 21444452410 scopus 로고    scopus 로고
    • Renal epithelia in long term gradient culture for biomaterial testing and tissue engineering
    • Minuth W W, Schumacher K and Strehl R 2005 Renal epithelia in long term gradient culture for biomaterial testing and tissue engineering Biomed. Mater. Eng. 15 51-63
    • (2005) Biomed. Mater. Eng. , vol.15 , pp. 51-63
    • Minuth, W.W.1    Schumacher, K.2    Strehl, R.3
  • 28
    • 33750029375 scopus 로고    scopus 로고
    • Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles
    • Bitterle E et al 2006 Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles Chemosphere 65 1784-90
    • (2006) Chemosphere , vol.65 , Issue.10 , pp. 1784-1790
    • Bitterle, E.1    Al, E.2
  • 29
    • 34047161596 scopus 로고    scopus 로고
    • Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea
    • Tan Q et al 2007 Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea Eur. J. Cardiothorac. Surg. 31 806-11
    • (2007) Eur. J. Cardiothorac. Surg. , vol.31 , Issue.5 , pp. 806-811
    • Tan, Q.1    Al, E.2
  • 30
    • 34249092703 scopus 로고    scopus 로고
    • Technical and theoretical considerations about gradient perfusion culture for epithelia used in tissue engineering, biomaterial testing and pharmaceutical research
    • Minuth W W and Strehl R 2007 Technical and theoretical considerations about gradient perfusion culture for epithelia used in tissue engineering, biomaterial testing and pharmaceutical research Biomed. Mater. 2 R1-11
    • (2007) Biomed. Mater. , vol.2 , Issue.2 , pp. 1-11
    • Minuth, W.W.1    Strehl, R.2
  • 31
    • 35348855017 scopus 로고    scopus 로고
    • Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in human breast epithelial cells
    • Kim I Y et al 2007 Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in human breast epithelial cells J. Biochem. Mol. Biol. 40 825-31
    • (2007) J. Biochem. Mol. Biol. , vol.40 , pp. 825-831
    • Kim, I.Y.1    Al, E.2
  • 32
    • 34247550164 scopus 로고    scopus 로고
    • Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: Implications for development and arthritis
    • Tchetina E V et al 2007 Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis Matrix Biol. 26 247-58
    • (2007) Matrix Biol. , vol.26 , Issue.4 , pp. 247-258
    • Tchetina, E.V.1    Al, E.2
  • 33
    • 34547173586 scopus 로고    scopus 로고
    • Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes
    • Gabriel D et al 2007 Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes Bioconjug. Chem. 18 1070-7
    • (2007) Bioconjug. Chem. , vol.18 , Issue.4 , pp. 1070-1077
    • Gabriel, D.1    Al, E.2
  • 34
    • 15344344686 scopus 로고    scopus 로고
    • Latent cytokines: Development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3
    • Vessillier S, Adams G and Chernajovsky Y 2004 Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3 Protein Eng. Des. Sel. 17 829-35
    • (2004) Protein Eng. Des. Sel. , vol.17 , Issue.12 , pp. 829-835
    • Vessillier, S.1    Adams, G.2    Chernajovsky, Y.3
  • 35
    • 19644367664 scopus 로고    scopus 로고
    • Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
    • Lutolf M P and Hubbell J A 2005 Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nat. Biotechnol. 23 47-55
    • (2005) Nat. Biotechnol. , vol.23 , Issue.1 , pp. 47-55
    • Lutolf, M.P.1    Hubbell, J.A.2
  • 36
    • 34447634505 scopus 로고    scopus 로고
    • Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury
    • Buss A et al 2007 Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury BMC Neurol. 7 17
    • (2007) BMC Neurol. , vol.7 , Issue.1 , pp. 17
    • Buss, A.1    Al, E.2
  • 37
    • 52649096753 scopus 로고    scopus 로고
    • TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease
    • Li Y et al 2006 TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease J. Huazhong Univ. Sci. Technol. Med. Sci. 26 647-50
    • (2006) J. Huazhong Univ. Sci. Technol. Med. Sci. , vol.26 , Issue.6 , pp. 647-650
    • Li, Y.1    Al, E.2
  • 38
    • 36849020581 scopus 로고    scopus 로고
    • Development of musculoskeletal toxicity without clear benefit after administration of PG 116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: A randomized, 12 month, double-blind, placebo-controlled study
    • Krzeski P et al 2007 Development of musculoskeletal toxicity without clear benefit after administration of PG 116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12 month, double-blind, placebo-controlled study Arthritis Res. Ther. 9 R109
    • (2007) Arthritis Res. Ther. , vol.9 , Issue.5 , pp. 109
    • Krzeski, P.1    Al, E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.